9:15 am. Welcome Introduction. Jaakko Tuomilehto and Rafael Gabriel, WCPD Foundation
The 1-hour plasma glucose as a novel biomarker for detecting dysglycaemia. Chair: Sudhirsen Kowlessur, Mauritius.
9:30-9:50 am. Background: Rationale, Pathophysiology and Overview. Jaakko Tuomilehto. Finland
9:50-10:10 am. Detection of Prediabetes and Type-2 Diabetes with 1-hour plasma glucose vs fasting plasma glucose and 2-hour plasma glucose. Ilham Satman, Turkey. 10:10:10:30 am. Discussion
Screening for complications in prediabetes Chair: Sebastián Mas, Spain
10:30-10:50 am: Screening for Peripheral Neuropathy in Prediabetes and the Metabolic Syndrome. Rafael Gabriel, Spain
10:50-11:10 am: Screening for diabetic Nephropathy. Jesús Egido, Spain
11:10-11:30 am: Discussion
11:30-12:00 Break
Update of the major T2D prevention trials. Chair: Segundo Seclén, Peru
12:00-12:20pm: US Diabetes Prevention Program: Ella. Temprosa, USA 12:20.12:40pm. Finnish Diabetes Prevention Study, Jaakko Tuomilehto, Finland 12:40-13:00 pm. Population-based prevention of type 2 diabetes in Mauritius. Sudhirsen Kowlessur, Mauritius.
13:00-13:20 pm Discussion
Conclusion remarks 13:30 pm. Rafael Gabriel, Jaakko Tuomilehto
NOTICE: No pre-registration needed. Free entrance